Lariam (mefloquine): Reviews and patient testimonials
Medication indications
Lariam 250 mg Tablets
Therapy and chemoprophylaxis of malaria.
Therapy: Lariam is especially indicated for therapy of P. falciparum malaria in which the pathogen has become resistant to other antimalarial agents.
Following treatment of P. vivax malaria with Lariam, radical cure with an 8-amino-quinoline derivative, for example primaquine, should be considered in order to eliminate parasites in the hepatic phase.
Chemoprophylaxis: Malaria chemoprophylaxis with Lariam is particularly recommended for travellers to malarious areas in which multiply resistant P. falciparum strains occur.
Official guidelines and local information on the prevalence of resistance to antimalarial drugs should be taken into consideration. Official guidelines will normally include WHO and public health authorities. For current advice on geographical resistance patterns and appropriate chemoprophylaxis, current guidelines or the National Travel Health Network and Centre (NaTHNaC) should be consulted, which can be found at http://travelhealthpro.org.uk/diseases/malaria.
Route of administration: Oral
Molecule: mefloquine
Patients' opinions on Lariam
In brief
General satisfaction level: Be the first to evaluate
Treatment's effectiveness: Be the first to evaluate
Ease of use: Be the first to evaluate
Adherence to prescription: Be the first to evaluate
Detected side effects: Be the first to evaluate
Improvement in the quality of life: Be the first to evaluate
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Not at all satisfied
10 = Extremely satisfied
1 = Never
10 = Always
1 = Not at all important
10 = Extremely important
1 = Not at all satisfied
10 = Extremely satisfied
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.